ORKA — Oruka Therapeutics, Inc.
No mentions collected in the last 24 hours.
ORKA — 오늘 왜 언급됐나 (2026-10-27)
- Oruka Therapeutics 주식이 2상 건선 임상 결과 긍정적이라며 12% 상승했다.
- ORKA-001은 경쟁사 스키리지보다 완전한 피부 소실 효과를 보였다.
Why people talked about ORKA
- Oruka Therapeutics stock rose 12% following positive results from its Phase 2b psoriasis trial.
- The drug ORKA-001 demonstrated superior complete clearance compared to competitor Skyrizi.